BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Personalized medicine
,
Clofibrate
,
rs6983267
,
DNMT1
,
Coagulation
,
Leukemia
,
Stem cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
fibroblast growth factor receptor- 1
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Expression and Purification of FGFR1-Fc Fusion Protein and Its Effects on Human Lung Squamous Carcin…
Protein Tyrosine Phosphatase Receptor Type G (PTPRG) Controls Fibroblast Growth Factor Receptor (FGF…
Role and Therapeutic Potential for Targeting Fibroblast Growth Factor 10/FGFR1 in Relapsed Rheumatoi…
Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single-a…
Fibroblast growth factor receptors 1 and 4 combined with lymph node metastasis predicts poor prognos…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alte…
A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor …
An Open-label Phase I Study of Orally Available Novel Small-molecule Fibroblast Growth Factor Recept…
Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth F…
Phase 1 Study of E7090 in Subjects With Solid Tumor
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ